Biotech & Life Sciences
O Atoll Financial Group (AFG) é uma empresa de consultoria e serviços financeiros sediada em Washington, D.C. especializada em auxiliar empresários no mundo todo a levantar o capital necessário para a realização de seus projetos através das muitas fontes internacionais de recursos financeiros com as quais o AFG se relaciona.
​
Além de negociar em nome do cliente e levantar recursos de curto e/ou longo prazo dentro do mercado de capitais internacional, exercemos também a função de conselheiro ou seja, auxiliamos com a apresentação e posicionamento dos projetos para que sejam bem recebido pelos investidores e/ou fontes de financiamento. O grande valor que oferemos não está apenas relacionado aos contatos que mantemos no mundo financeiro global, e sim a nossa capacidade em criar modelos e processos de financiamentos que sejam viáveis e ideais para o sucesso dos projetos dos nossos clientes.
​
Seja a sua visão de negócio direcionada ao financiamento de projetos, venture capital, equity financing ou qualquer outro tipo de financiamento de investimento, nossa cobertura é global e abrange uma ampla gama de segmentos.
​
Nossa força provém de um profundo conhecimento da indústria financeira, do sólido relacionamento que mantemos com diversas fontes de financiamento e de nossa talentosa e competente equipe com mentalidade focada em solução. Atuando a seu lado e trabalhando diretamente com um grupo diversificado de investidores e mutuantes, proporcionamos a sua empresa o mais competitivo instrumento de financiamento. é através de uma cultura de responsabilidade mútua e compromisso com a excelência que satisfazemos as necessidades de financiamento dos nossos clientes.
Lower and Lower-Middle Market Companies
Team
Dr. Sergio Botero
Lead Advisor
Biotech & Life Sciences
Sergio Botero is both a strategist and a scientist bringing a broad range of scientific and engineering expertise to Atoll by bridging technical and financial aspects of projects. Sergio’s academic background started with two Bachelors of Science degrees, in Biology and Microbiology, and a Master of Science degree in Biological Sciences with emphasis on Ecology and Primatology, all at Universidad de los Andes in his home country of Colombia. >>>
​
Jin Young Kim
Research Associate
Biotech & Life Sciences
Jin Young Kim is a Ph.D. candidate in Molecular and Cell Biology at University of California, Berkeley, where she developed a novel CRISPRi-based method using RNA barcodes to investigate genetic regulators of human genes and mRNAs. She earned her Bachelor of Science degree in Biochemistry and Cell Biology from Rice University, where she conducted research in synthetic biology, engineering proteins, and developing biological sensors. >>>>
​
​​
Dr. Deborah Sementa
Associate Director
Biotech & Life Sciences
Scientific strategist with profound expertise in biotechnology, life sciences, and finance, able to provide a holistic understanding of both sides of a biotech business.
In her home country of Italy, Deborah pursued a Master of Science degree in Pharmacy from Università degli Studi di Siena and a PhD in Medicinal chemistry from Università degli Studi di Napoli Federico II. >>>>​​
​
​
​
Wei-Yu Chi
Research Associate
Biotech & Life Sciences
Wei-Yu Chi is a medical doctor and current Ph.D. candidate at Weill Cornell Medicine, specializing in the development of single-cell sequencing technologies. With a focus on oncology, he is pioneering a novel sequencing method to profile transcription factor binding in single cells—a critical advance for understanding blood cancers such as leukemia and lymphoma and identifying potential drug targets. >>>>​
​​
José Estabil
Strategic Advisor
Biotech & Life Sciences
José Estabil is a connector and technology innovator in the life sciences. His recent executive roles focus on AI-assisted precision medicine. José translated cutting edge genomics and optics into profitable molecular diagnostics (Cipherome), chip diagnostics (KLA), and semiconductor devices (IBM) that resulted in reducing the risk of leg amputations, cost-effective semiconductor manufacturing, and faster circuits, respectively. >>>>
​
​​
JJ Carrasco
Managing Partner
A visionary and veteran of the financial industry, JJ Carrasco established Atoll Financial Group to meet the unique needs of businesses looking for innovative structured project finance and other complex financing alternatives. As Managing Partner, JJ is responsible for the overall company strategy and management of all business processes, strategic partnerships, product development and market feasibility analysis, staffing, and more. >>>
Lauren Dierdorff
Research Associate
Biotech & Life Sciences
Lauren Dierdorff is a Ph.D. candidate in Neuroscience at the Icahn School of Medicine at Mount Sinai, conducting translational research in the De Rubeis lab within the Seaver Autism Center for Research and Treatment and Department of Psychiatry. Her work focuses on the cortical circuits underlying motor deficits in a model of DDX3X syndrome, a rare genetic neurodevelopmental disorder. >>>>
​
​​
Jonathan Hakala
Partner | Managing Director of Capital Markets
As Managing Director of Capital Markets, Jonathan Hakala brings a wealth of senior financial, managerial and board-level experience to this leadership position helping to oversee capital markets activities for the Atoll Financial Group. Jonathan's senior financial, managerial and board-level expertise helps the Atoll Financial Group team pursue the best possible financial solutions for our clients. >>>